The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

(Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted ...

Shares of Hologic Inc. HOLX slipped 1.46% to $63.53 Wednesday, on what proved to be an all-around rough trading session for ...

Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $40.00 Call had some of the highest implied ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

Louisiana State Employees Retirement System decreased its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent 13F filing with ...

HOLX reported adjusted earnings per share (EPS) of $1.03 in the first quarter of fiscal 2025, up 5.1% year over year. The metric surpassed the Zacks Consensus Estimate by 0.9%. The adjustments include ...